Biognosys Launches Spectronaut 16 and Presents Major Advances to its Proteomics Platforms at the ASMS 2022 Annual Conference
Biognosys, a leading inventor and developer of mass spectrometry-based proteomics solutions, today announced the company…
Biognosys, a leading inventor and developer of mass spectrometry-based proteomics solutions, today announced the company…
Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today the deta…
Biognosys, a leader in proteomics solutions for drug discovery and development, today announces the launch of its next-g…
. - Expanding collaboration to develop FDA-regulated diagnostics based on exosomes to measure gene mutations targeted b…
. - Molecular testing of biofluids promises unprecedented access to gene mutations, gene expression signatures and expr…
Cellon SA announced today that their entire range of PharmaTainer(TM) bottles and carboys are now certified "clean," mee…
Cellon SA, specializing in providing products and services to the vaccine production and bioprocessing industries, annou…